Table 2.

Postoperative characteristics related to VTD application

	n (%)
Fascia-to-fascia distance (cm) 48 h at relook laparotomy after device application (range)	10 (6–17)
Duration of OA until device application; days (range)	3 (0–14)
Total duration of OA; days (range)	11 (5–28)
Duration of OA until fascial closure after device application; days (range)	7 (3–24)
Number of relook procedures until PFC; (range)	4 (1–7)
Successful early PFC	20 (100%)
Complications after skin and PFC
Subcutaneous wound dehiscence	4 (20%)
Fascial dehiscence	2 (10%)
Vertical traction device related complications
Pressure sores	1 (5%)
Intra-abdominal hypertension (IAH)	0 (0%)
Hemodynamic impairment	0 (0%)
Respiratory impairment	0 (0%)
In-clinic mortality	0 (0%)
Complications during follow-up
Incisional hernia	2 (10%)
Mortality (due to COVID-19 infection)	1 (5%)
Follow-up time, months (range)	8.5 (6–19)

Data are presented as mean (range) and are based on the total patient cohort (n = 20). OA open abdomen, PFC primary fascial closure, VDT vertical traction device